Spectrum Pharmaceuticals SG&A Expense Quarterly:
27.24M for Dec. 31, 2012Spectrum Pharmaceuticals Historical SG&A Expense Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 27.24M |
| Sept. 30, 2012 | 23.11M |
| June 30, 2012 | 23.35M |
| March 31, 2012 | 18.26M |
| Dec. 31, 2011 | 25.29M |
| Sept. 30, 2011 | 15.81M |
| June 30, 2011 | 18.70M |
| March 31, 2011 | 12.75M |
| Dec. 31, 2010 | 12.48M |
| Sept. 30, 2010 | 11.41M |
| June 30, 2010 | 13.80M |
| March 31, 2010 | 10.86M |
| Dec. 31, 2009 | 11.07M |
| Sept. 30, 2009 | 6.995M |
| June 30, 2009 | 9.192M |
| March 31, 2009 | 6.351M |
| Dec. 31, 2008 | 6.209M |
| Sept. 30, 2008 | 3.132M |
| June 30, 2008 | 3.23M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About SG&A Expense
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
Learn More
SPPI SG&A Expense Quarterly Benchmarks
| Companies | |
|---|---|
| Elan | 33.40M |
| Agenus | 2.891M |
| Biocryst Pharmaceuticals | 1.382M |
SPPI SG&A Expense Quarterly Rankings
| Overall |
74th percentile 2031 of 8005 |
| Sector |
75th percentile 170 of 686 in Healthcare |
| Industry |
88th percentile 29 of 248 in Biotechnology |
SPPI SG&A Expense Quarterly Range, Past 5 Years
| Minimum | 3.132M | Sep 2008 |
| Maximum | 27.24M | Dec 2012 |
| Average | 13.64M |
